Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action.
Martínez-Serra J, Maffiotte E, Martín J, Bex T, Navarro-Palou M, Ros T, Plazas JM, Vögler O, Gutiérrez A, Amat JC, Ramos R, Saus C, Ginés J, Alemany R, Diaz M, Besalduch J.
Martínez-Serra J, et al. Among authors: alemany r.
Eur J Pharmacol. 2011 May 11;658(2-3):57-64. doi: 10.1016/j.ejphar.2011.02.035. Epub 2011 Mar 1.
Eur J Pharmacol. 2011.
PMID: 21371453